ATRC AtriCure, Inc. Stock Quote

ATRC [NASD]

Healthcare | Medical Instruments & Supplies | USA

Index	-	P/E	-	EPS (ttm)	-1.18	Insider Own	2.10%	Shs Outstand	45.57M	Perf Week	-5.67%
Market Cap	2.80B	Forward P/E	-	EPS next Y	-0.86	Insider Trans	-35.22%	Shs Float	44.28M	Perf Month	7.07%
Income	-48.20M	PEG	-	EPS next Q	-0.37	Inst Own	98.30%	Short Float	4.51%	Perf Quarter	42.09%
Sales	206.50M	P/S	13.57	EPS this Y	-22.10%	Inst Trans	2.44%	Short Ratio	4.99	Perf Half Y	43.79%
Book/sh	9.79	P/B	6.39	EPS next Y	25.90%	ROA	-7.30%	Target Price	70.14	Perf Year	69.19%
Cash/sh	5.45	P/C	11.48	EPS next 5Y	20.00%	ROE	-13.10%	52W Range	23.17 - 68.00	Perf YTD	12.36%
Dividend	-	P/FCF	-	EPS past 5Y	-3.30%	ROI	-9.30%	52W High	-8.01%	Beta	1.06
Dividend %	-	Quick Ratio	5.50	Sales past 5Y	9.70%	Gross Margin	72.30%	52W Low	170.02%	ATR	2.90
Employees	750	Current Ratio	6.20	Sales Q/Q	-5.90%	Oper. Margin	-21.40%	RSI (14)	49.48	Volatility	5.74% 4.46%
Optionable	Yes	Debt/Eq	0.16	EPS Q/Q	-4.60%	Profit Margin	-23.30%	Rel Volume	0.67	Prev Close	63.73
Shortable	Yes	LT Debt/Eq	0.16	Earnings	Feb 23 AMC	Payout	-	Avg Volume	400.30K	Price	62.55
Recom	1.40	SMA20	-2.58%	SMA50	4.14%	SMA200	32.33%	Volume	271,240	Change	-1.85%

Dec-18-20

Reiterated

Needham

Buy

$53 → $63

Nov-06-20

Reiterated

Needham

Buy

$63 → $53

Apr-07-20

Initiated

Oppenheimer

Outperform

$45

Feb-06-20

Initiated

BTIG Research

Buy

$42

Jan-24-20

Reiterated

Needham

Buy

$39 → $48

Aug-13-19

Downgrade

Northland Capital

Outperform → Market Perform

$30

Apr-12-19

Initiated

JP Morgan

Overweight

$37

Oct-04-18

Reiterated

Needham

Buy

$36 → $39

Aug-02-18

Reiterated

Stifel

Buy

$32 → $34

Aug-02-18

Reiterated

Needham

Buy

$32 → $36

Jun-18-18

Reiterated

Needham

Buy

$26 → $32

Apr-27-18

Reiterated

Needham

Buy

$23 → $26

Jan-16-18

Reiterated

Needham

Buy

$25 → $23

Nov-02-17

Reiterated

Needham

Buy

$26 → $25

Jul-28-17

Reiterated

Needham

Buy

$25 → $26

May-30-17

Resumed

Piper Jaffray

Overweight

Jun-30-16

Resumed

JMP Securities

Mkt Outperform

Oct-28-15

Reiterated

Needham

Buy

$30 → $23

Oct-06-15

Reiterated

Needham

Buy

$32 → $30

Oct-06-15

Reiterated

Canaccord Genuity

Buy

$31 → $28

Mar-02-21 04:01PM	AtriCure to Participate at the Oppenheimer 31st Annual Healthcare Conference Business Wire
Feb-24-21 03:01AM	AtriCure Inc (ATRC) Q4 2020 Earnings Call Transcript Motley Fool
Feb-23-21 04:25PM	AtriCure: Q4 Earnings Insights Benzinga
04:01PM	AtriCure Reports Fourth Quarter 2020 and Full Year 2020 Financial Results Business Wire
02:30PM	AtriCure, Inc. to Host Earnings Call ACCESSWIRE
Feb-22-21 10:19AM	Earnings Preview: AtriCure Benzinga
Feb-10-21 08:00AM	AtriCure to Participate at the SVB Leerink 10th Annual Global Healthcare Conference Business Wire
Feb-02-21 08:00AM	AtriCure to Announce Fourth Quarter and Full Year 2020 Financial Results Business Wire
Jan-25-21 11:57PM	Have Insiders Been Buying AtriCure, Inc. (NASDAQ:ATRC) Shares This Year? Simply Wall St.
Jan-12-21 08:15AM	The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue Benzinga
Jan-11-21 07:00AM	AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2020 Business Wire
Jan-04-21 08:00AM	AtriCure Announces Labeling Expansion for Cryo Nerve Block Therapy Business Wire
Dec-21-20 08:42AM	AtriCure (ATRC) Looks Good: Stock Adds 5.1% in Session Zacks
12:12AM	Does AtriCure (NASDAQ:ATRC) Have A Healthy Balance Sheet? Simply Wall St.
Dec-19-20 04:45PM	Is ATRC A Good Stock To Buy Now According To Hedge Funds? Insider Monkey
Dec-14-20 08:00AM	AtriCure to Participate in the 39th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-04-20 12:00PM	AtriCure (ATRC) Upgraded to Buy: Here's What You Should Know Zacks
Nov-19-20 11:44AM	Insider Buys AtriCure Stock Benzinga +5.00%
08:00AM	AtriCure to Participate in Upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference Business Wire
Nov-06-20 09:30AM	AtriCure Inc (ATRC) Q3 2020 Earnings Call Transcript Motley Fool
Nov-05-20 06:25PM	AtriCure (ATRC) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:01PM	AtriCure Reports Third Quarter 2020 Financial Results Business Wire
02:30PM	AtriCure, Inc. to Host Earnings Call ACCESSWIRE
Oct-29-20 12:35PM	Analysts Estimate AtriCure (ATRC) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-26-20 08:00AM	AtriCure to Participate in Upcoming Investor Conferences Business Wire
Oct-13-20 08:00AM	AtriCure to Announce Third Quarter 2020 Financial Results Business Wire
Oct-06-20 05:41PM	Do Hedge Funds Love AtriCure Inc. (ATRC)? Insider Monkey
Sep-28-20 06:39AM	What We Learned About AtriCure's (NASDAQ:ATRC) CEO Compensation Simply Wall St.
Sep-01-20 08:00AM	AtriCure to Participate at the Morgan Stanley 18th Annual Global Healthcare Conference Business Wire
Aug-06-20 04:00PM	AtriCure Announces Angie Wirick as Chief Financial Officer Business Wire
Aug-03-20 08:55AM	AtriCure Inc. (ATRC): Were Hedge Funds Right About Buying This Stock? Insider Monkey
Jul-30-20 06:39AM	Analysts Have Made A Financial Statement On AtriCure, Inc.'s (NASDAQ:ATRC) Second-Quarter Report Simply Wall St.
Jul-29-20 08:00AM	AtriCure to Participate at Upcoming Investor Conferences Business Wire -5.13%
05:01AM	AtriCure Inc (ATRC) Q2 2020 Earnings Call Transcript Motley Fool
Jul-28-20 04:22PM	Recap: AtriCure Q2 Earnings Benzinga
04:01PM	AtriCure Reports Second Quarter 2020 Financial Results Business Wire
Jul-21-20 12:31PM	Analysts Estimate AtriCure (ATRC) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-07-20 08:00AM	AtriCure to Announce Second Quarter 2020 Financial Results Business Wire -6.39%
Jun-19-20 12:45PM	Hedge Funds Are Buying AtriCure Inc. (ATRC) Insider Monkey
Jun-17-20 04:53AM	Edited Transcript of ATRC.OQ earnings conference call or presentation 29-Apr-20 8:30pm GMT Thomson Reuters StreetEvents
May-11-20 08:10PM	AtriCure Announces Pricing of Public Offering of Common Stock Business Wire
07:16AM	AtriCure Announces Proposed Public Offering of Common Stock Business Wire
May-08-20 08:47AM	AtriCure Announces Results from CONVERGE IDE Clinical Trial Business Wire +7.70%
Apr-30-20 11:00AM	AtriCure Inc (ATRC) Q1 2020 Earnings Call Transcript Motley Fool
08:30AM	AtriCure Announces Investor Update Webcast on May 8, 2020 in Conjunction with the 41st Annual Heart Rhythm Society (HRS) Virtual Meeting Business Wire
Apr-29-20 05:25PM	AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates Zacks +5.61%
04:01PM	AtriCure Reports First Quarter 2020 Financial Results Business Wire
Apr-27-20 04:02PM	AtriCure to Participate at Upcoming Investor Conferences Business Wire
Apr-22-20 12:31PM	Analysts Estimate AtriCure (ATRC) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-15-20 08:00AM	AtriCure to Announce First Quarter 2020 Financial Results Business Wire
Apr-14-20 06:42AM	Some Analysts Just Cut Their AtriCure, Inc. (NASDAQ:ATRC) Estimates Simply Wall St.
Apr-13-20 08:00AM	AtriCure Announces CONVERGE IDE Trial Results Accepted for Late-Breaking Clinical Trial Sessions at Annual Heart Rhythm Society (HRS) Meeting Business Wire
Apr-09-20 12:26PM	AtriCure C-suite taking pay cuts as revenue dips because of coronavirus American City Business Journals
08:00AM	AtriCure Announces Preliminary Financial Results for First Quarter 2020 and Provides COVID-19 Pandemic Update Business Wire
Apr-06-20 04:14PM	Dayton stocks reap massive gains as broad market skyrockets American City Business Journals +7.52%
Apr-01-20 03:00PM	Dayton stocks dive again after Q1 registers biggest drop since 2008 American City Business Journals
Mar-24-20 05:09PM	These Dayton stocks skyrocketed as market posts best day since 1933 American City Business Journals +9.52%
Mar-23-20 02:29PM	Here's how Dayton stocks fared as Dow falls to lowest level since 2016 American City Business Journals
Mar-12-20 09:21AM	Dayton stocks tumble as Dow falls, ending 11-year bull run American City Business Journals -13.35%
Feb-28-20 02:53PM	Dayton stocks face sharp declines as equity market tumbles American City Business Journals
Feb-25-20 10:37PM	Edited Transcript of ATRC earnings conference call or presentation 18-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
Feb-20-20 05:54AM	US$49.43 - That's What Analysts Think AtriCure, Inc. Is Worth After These Results Simply Wall St.
Feb-18-20 04:01PM	AtriCure Reports Fourth Quarter 2019 and Full Year 2019 Financial Results Business Wire
02:30PM	AtriCure, Inc. to Host Earnings Call ACCESSWIRE
Feb-03-20 08:00AM	AtriCure to Participate at the SVB Leerink 9th Annual Global Healthcare Conference Business Wire
Jan-31-20 07:33AM	Is AtriCure (NASDAQ:ATRC) Using Debt Sensibly? Simply Wall St.
Jan-28-20 11:15AM	Here's how Dayton-area stocks performed in 2019 American City Business Journals
08:00AM	AtriCure to Announce Fourth Quarter and Full Year 2019 Financial Results Business Wire
Jan-10-20 08:14AM	AtriCure Enters Overbought Territory Zacks
Jan-07-20 08:00AM	AtriCure Announces Successful Completion of Patient Enrollment of aMAZE Clinical Trial and FDA Approval of Continued Access Protocol Business Wire
Dec-16-19 08:00AM	AtriCure to Participate at the 38th Annual JP Morgan Healthcare Conference Business Wire
Dec-10-19 11:28AM	Why AtriCure CEO Mike Carrel wants title of heart surgeon for a day American City Business Journals
Dec-09-19 01:12PM	Did Hedge Funds Drop The Ball On AtriCure Inc. (ATRC) ? Insider Monkey
Dec-05-19 06:13AM	Medical device maker south of Dayton gets board refresh American City Business Journals
Dec-04-19 08:00AM	AtriCure Names Two Industry Veterans to Board of Directors Business Wire
Dec-02-19 09:33AM	Is AtriCure, Inc.'s (NASDAQ:ATRC) CEO Paid Enough Relative To Peers? Simply Wall St.
Nov-12-19 08:00AM	AtriCure to Participate at the Piper Jaffray 31st Annual Healthcare Conference Business Wire
Nov-06-19 02:22PM	Edited Transcript of ATRC earnings conference call or presentation 30-Oct-19 8:30pm GMT Thomson Reuters StreetEvents
Oct-30-19 06:15PM	AtriCure (ATRC) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:02PM	AtriCure Reports Third Quarter 2019 Financial Results Business Wire
Oct-27-19 02:02PM	Is AtriCure Inc. (ATRC) A Good Stock To Buy ? Insider Monkey
Oct-23-19 10:33AM	Analysts Estimate AtriCure (ATRC) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-21-19 08:00AM	AtriCure to Participate in Upcoming Investor Conferences Business Wire
Oct-09-19 06:18PM	This Hedge Fund Returns 22% Annually, Here Are Its Latest Picks Insider Monkey
Oct-08-19 11:06AM	Does AtriCure's (NASDAQ:ATRC) Share Price Gain of 64% Match Its Business Performance? Simply Wall St.
08:00AM	AtriCure to Announce Third Quarter 2019 Financial Results Business Wire
Sep-02-19 03:18PM	How AtriCure, Inc.'s (NASDAQ:ATRC) Earnings Growth Stacks Up Against The Industry Simply Wall St.
Aug-28-19 10:50AM	AtriCure Gains Expanded Labeling for Atriclip, Braces LAA Arm Zacks
Aug-27-19 08:00AM	AtriCure Receives Clearance for Expanded Labeling Claims for AtriClip Devices Business Wire
Aug-26-19 08:00AM	AtriCure to Participate at the Morgan Stanley 17th Annual Global Healthcare Conference Business Wire
Aug-14-19 02:26PM	The Funded: 6 Bay Area companies raise $274M at midweek American City Business Journals
Aug-13-19 02:16PM	AtriCure Completes Acquisition of SentreHEART Business Wire -5.09%
Aug-12-19 11:04AM	AtriCure could pay up to $300M to acquire California firm American City Business Journals
05:30AM	AtriCure Enters Into Definitive Agreement to Acquire SentreHEART Business Wire
Jul-31-19 02:39PM	Edited Transcript of ATRC earnings conference call or presentation 30-Jul-19 8:30pm GMT Thomson Reuters StreetEvents
08:24AM	AtriCure Inc (ATRC) Q2 2019 Earnings Call Transcript Motley Fool
Jul-30-19 06:35PM	AtriCure (ATRC) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:02PM	AtriCure Reports Second Quarter 2019 Financial Results Business Wire
02:30PM	AtriCure, Inc. to Host Earnings Call ACCESSWIRE
Jul-26-19 02:09PM	AtriCure (NASDAQ:ATRC) May Be Weighed Down By Its Debt Simply Wall St.

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers in the United States and internationally. The company offers Isolator Synergy and Isolator Synergy Access clamps for the treatment of persistent and long-standing persistent atrial fibrillation concomitant to other open-heart surgical procedures; EPi-Sense guided coagulation system used for the coagulation of tissue; and COBRA Fusion surgical ablation system to combine bipolar temperature-controlled radio frequency energy control with monopolar energy. It also provides multifunctional pens that allow surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and linear ablation devices, which enable users to make longer linear lines of ablation. In addition, the company offers cryoICE cryoablation system used to ablate cardiac tissue for the treatment of cardiac arrhythmias; AtriClip system used to occlude the left atrial appendage by mechanically clamping the appendage; and CryoICE CRYO2 cryoablation system to apply cryo-energy to targeted intercostal peripheral nerves in the ribcage and temporarily relieve pain. Further, it provides Lumitip dissector to separate tissues to provide access to key anatomical structures that are targeted for ablation; Fusion Magnetic Retriever System that allows access around anatomical structures; and cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. The company sells its products through independent distributors and direct sales personnel. The company was founded in 2000 and is headquartered in Mason, Ohio.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
CARREL MICHAEL H	President, CEO, & Director	Feb 12	Option Exercise	21.04	25,000	526,000	529,795	Feb 12 04:30 PM
CARREL MICHAEL H	President, CEO, & Director	Feb 12	Sale	65.00	25,000	1,625,000	504,795	Feb 12 04:30 PM
CARREL MICHAEL H	President, CEO, & Director	Feb 11	Option Exercise	21.04	25,000	526,000	529,795	Feb 12 04:30 PM
CARREL MICHAEL H	President, CEO, & Director	Feb 11	Sale	64.00	25,000	1,600,000	504,795	Feb 12 04:30 PM
CARREL MICHAEL H	President, CEO, & Director	Feb 10	Option Exercise	21.04	25,000	526,000	529,795	Feb 12 04:30 PM
CARREL MICHAEL H	President, CEO, & Director	Feb 10	Sale	63.00	25,000	1,575,000	504,795	Feb 12 04:30 PM
CARREL MICHAEL H	President, CEO, & Director	Feb 09	Option Exercise	21.04	25,000	526,000	529,795	Feb 10 08:52 AM
CARREL MICHAEL H	President, CEO, & Director	Feb 09	Sale	62.00	25,000	1,550,000	504,795	Feb 10 08:52 AM
CARREL MICHAEL H	President, CEO, & Director	Feb 08	Option Exercise	21.04	25,000	526,000	529,795	Feb 10 08:52 AM
CARREL MICHAEL H	President, CEO, & Director	Feb 08	Sale	61.00	25,000	1,525,000	504,795	Feb 10 08:52 AM
CARREL MICHAEL H	President, CEO, & Director	Feb 02	Option Exercise	21.04	25,000	526,000	529,795	Feb 04 09:03 AM
Seith Douglas J	Chief Operating Officer	Feb 02	Sale	60.00	14,941	896,460	95,939	Feb 04 09:06 AM
CARREL MICHAEL H	President, CEO, & Director	Feb 02	Sale	60.00	25,000	1,500,000	504,795	Feb 04 09:03 AM
CARREL MICHAEL H	President, CEO, & Director	Jan 11	Option Exercise	21.04	25,000	526,000	529,795	Jan 13 04:27 PM
CARREL MICHAEL H	President, CEO, & Director	Jan 11	Sale	59.00	25,000	1,475,000	504,795	Jan 13 04:27 PM
Noznesky Justin J	SVP, Mktg & Business Develop	Jan 04	Option Exercise	18.30	15,000	274,500	66,005	Jan 06 07:45 AM
Collar Mark A	Director	Jan 04	Sale	55.36	3,000	166,080	75,558	Jan 06 07:47 AM
Noznesky Justin J	SVP, Mktg & Business Develop	Jan 04	Sale	53.58	23,397	1,253,713	42,608	Jan 06 07:45 AM
CARREL MICHAEL H	President, CEO, & Director	Dec 28	Option Exercise	21.04	24,953	525,011	529,457	Dec 28 08:09 PM
CARREL MICHAEL H	President, CEO, & Director	Dec 28	Sale	58.00	24,953	1,447,274	504,504	Dec 28 08:09 PM
CARREL MICHAEL H	President, CEO, & Director	Dec 23	Option Exercise	21.04	47	989	504,551	Dec 28 08:09 PM
CARREL MICHAEL H	President, CEO, & Director	Dec 23	Sale	58.00	47	2,726	504,504	Dec 28 08:09 PM
CARREL MICHAEL H	President, CEO, & Director	Dec 22	Option Exercise	21.04	50,000	1,052,000	529,594	Dec 23 04:23 PM
CARREL MICHAEL H	President, CEO, & Director	Dec 22	Sale	56.50	50,000	2,825,000	504,504	Dec 23 04:23 PM
CARREL MICHAEL H	President, CEO, & Director	Dec 21	Option Exercise	21.04	24,751	520,761	529,255	Dec 23 04:23 PM
CARREL MICHAEL H	President, CEO, & Director	Dec 21	Sale	55.00	24,751	1,361,305	504,504	Dec 23 04:23 PM
CARREL MICHAEL H	President, CEO, & Director	Dec 18	Option Exercise	21.04	50,249	1,057,239	554,753	Dec 21 05:07 PM
CARREL MICHAEL H	President, CEO, & Director	Dec 18	Sale	53.51	50,249	2,688,824	504,504	Dec 21 05:07 PM
CARREL MICHAEL H	President, CEO, & Director	Dec 17	Option Exercise	10.95	75,000	821,500	529,504	Dec 21 05:07 PM
CARREL MICHAEL H	President, CEO, & Director	Dec 17	Sale	51.00	75,000	3,825,000	504,504	Dec 21 05:07 PM
Privitera Salvatore	Chief Technical Officer	Dec 17	Sale	51.33	10,654	546,870	68,262	Dec 21 05:03 PM
Seith Douglas J	Chief Operating Officer	Dec 17	Sale	50.00	18,617	930,850	110,880	Dec 21 05:00 PM
Privitera Salvatore	Chief Technical Officer	Dec 09	Sale	47.50	3,846	182,685	78,916	Dec 11 07:52 AM
Drake Scott William	Director	Nov 17	Buy	40.54	12,350	500,669	41,036	Nov 19 07:40 AM
Seith Douglas J	Chief Operating Officer	Oct 09	Sale	40.09	29,161	1,169,064	129,497	Oct 13 08:23 AM
Collar Mark A	Director	Oct 06	Sale	40.00	2,330	93,200	78,558	Oct 08 08:39 AM
Collar Mark A	Director	Oct 01	Sale	40.20	670	26,934	80,888	Oct 05 08:45 AM
GROVES REGINA E	Director	Sep 14	Sale	41.83	6,313	264,073	21,809	Sep 16 04:12 PM
Collar Mark A	Director	Jul 01	Sale	44.60	4,000	178,400	81,558	Jul 06 08:21 AM
Collar Mark A	Director	May 12	Option Exercise	5.15	10,000	51,500	83,106	May 14 08:12 AM
CARREL MICHAEL H	President, CEO, & Director	May 12	Option Exercise	5.91	25,000	147,750	539,147	May 13 04:57 PM
CARREL MICHAEL H	President, CEO, & Director	May 12	Sale	47.00	25,000	1,175,000	514,147	May 13 04:57 PM
CARREL MICHAEL H	President, CEO, & Director	May 11	Option Exercise	5.91	25,000	147,750	539,147	May 13 04:57 PM
CARREL MICHAEL H	President, CEO, & Director	May 11	Sale	46.00	25,000	1,150,000	514,147	May 13 04:57 PM
CARREL MICHAEL H	President, CEO, & Director	May 08	Option Exercise	5.91	25,000	147,750	539,147	May 08 05:02 PM
CARREL MICHAEL H	President, CEO, & Director	May 08	Sale	45.00	25,000	1,125,000	514,147	May 08 05:02 PM
Lanning Mark R	Director	Apr 27	Option Exercise	5.15	10,000	51,500	128,434	Apr 29 08:03 AM
Noznesky Justin J	SVP, Mktg & Business Develop	Apr 17	Sale	40.00	10,000	400,000	51,255	Apr 20 08:01 AM
Collar Mark A	Director	Apr 07	Sale	36.07	4,000	144,280	73,106	Apr 09 08:09 AM
Noznesky Justin J	SVP, Mktg & Business Develop	Apr 07	Sale	35.00	10,000	350,000	61,255	Apr 09 08:05 AM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience